These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12804005)
1. Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression. Chuenchitra T; Wasi C; Louisirirojchanakul S; Nitayaphan S; Sutthent R; Cox JH; De Souza MS; Brown AE; Birx DL; Polonis VR AIDS Res Hum Retroviruses; 2003 Apr; 19(4):293-305. PubMed ID: 12804005 [TBL] [Abstract][Full Text] [Related]
2. CRF01_AE-specific neutralizing activity observed in plasma derived from HIV-1-infected Thai patients residing in northern Thailand: comparison of neutralizing breadth and potency between plasma derived from rapid and slow progressors. Sapsutthipas S; Tsuchiya N; Pathipavanich P; Ariyoshi K; Sawanpanyalert P; Takeda N; Isarangkura-na-ayuthaya P; Kameoka M PLoS One; 2013; 8(1):e53920. PubMed ID: 23308290 [TBL] [Abstract][Full Text] [Related]
3. Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection. Kim JH; Mascola JR; Ratto-Kim S; VanCott TC; Loomis-Price L; Cox JH; Michael NL; Jagodzinski L; Hawkes C; Mayers D; Gilliam BL; Birx DC; Robb ML AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1021-34. PubMed ID: 11485619 [TBL] [Abstract][Full Text] [Related]
4. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand. Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476 [TBL] [Abstract][Full Text] [Related]
5. Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1. Kim JH; Pitisuttithum P; Kamboonruang C; Chuenchitra T; Mascola J; Frankel SS; DeSouza MS; Polonis V; McLinden R; Sambor A; Brown AE; Phonrat B; Rungruengthanakit K; Duliege AM; Robb ML; McNeil J; Birx DL; AIDS Res Hum Retroviruses; 2003 Sep; 19(9):807-16. PubMed ID: 14585211 [TBL] [Abstract][Full Text] [Related]
6. Characterization of sera from subjects infected with HIV-1 subtypes B and E in Thailand by antibody binding and neutralization. Louisirirotchanakul S; Beddows S; Cheingsong-Popov R; Shaffer N; Mastro TD; Auewarakul P; Likanonsakul S; Wasi C; Weber J J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):315-20. PubMed ID: 9833739 [TBL] [Abstract][Full Text] [Related]
7. B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses. Oballah P; Flach B; Eller LA; Eller MA; Ouma B; de Souza M; Kibuuka HN; Wabwire-Mangen F; Brown BK; Michael NL; Robb ML; Montefiori D; Polonis VR PLoS One; 2011; 6(8):e22653. PubMed ID: 21886768 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression. Chuenchitra T; Wasi C; de Souza M; Nitayaphan S; Louisirirotchanakul S; Sutthent R; Brown AE; Birx DL; Polonis VR Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):856-62. PubMed ID: 19058580 [TBL] [Abstract][Full Text] [Related]
9. HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies. Polonis VR; De Souza MS; Chanbancherd P; Chantakulkij S; Jugsudee A; Loomis-Price LD; Vancott TC; Garner R; Markowitz LE; Brown AE; Birx DL AIDS Res Hum Retroviruses; 2001 Jan; 17(1):69-79. PubMed ID: 11177385 [TBL] [Abstract][Full Text] [Related]
10. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response. Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity. Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591 [TBL] [Abstract][Full Text] [Related]
12. Cytokine profiles in HIV-1 subtype CRF01_AE infected individuals with different rates of diseases progression: a multiplex immunoassay. Chuenchitra T; Chaitaveep P; Sukwit S; Dettrairat S; Tabprasit S; Srisurapanon S; Kohreanudom S; Kuvanont D; Sutthent R; Sirisopana N; Nitayaphan S J Med Assoc Thai; 2012 May; 95 Suppl 5():S116-23. PubMed ID: 22934457 [TBL] [Abstract][Full Text] [Related]
13. Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes. Komoto S; Kinomoto M; Ibrahim MS; Zhong Q; Auwanit W; Ayuthaya PI; Otake T; Mori H; Oishi I; Kurosu T; Takahashi H; Mukai T; Ikuta K Vaccine; 2001 Apr; 19(20-22):3019-32. PubMed ID: 11282214 [TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients. Polonis VR; de Souza MS; Darden JM; Chantakulkij S; Chuenchitra T; Nitayaphan S; Brown AE; Robb ML; Birx DL J Virol; 2003 Aug; 77(15):8570-6. PubMed ID: 12857927 [TBL] [Abstract][Full Text] [Related]
15. Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy. Hu X; Hong K; Zhao C; Zheng Y; Ma L; Ruan Y; Gao H; Greene K; Sarzotti-Kelsoe M; Montefiori DC; Shao Y J Gen Virol; 2012 Oct; 93(Pt 10):2267-2278. PubMed ID: 22791603 [TBL] [Abstract][Full Text] [Related]
16. Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies. Kuriakose Gift S; Wieczorek L; Sanders-Buell E; Zemil M; Molnar S; Donofrio G; Townsley S; Chenine AL; Bose M; Trinh HV; Barrows BM; Sriplienchan S; Kitsiripornchai S; Nitayapan S; Eller LA; Rao M; Ferrari G; Michael NL; Ake JA; Krebs SJ; Robb ML; Tovanabutra S; Polonis VR J Virol; 2023 Feb; 97(2):e0163522. PubMed ID: 36749076 [TBL] [Abstract][Full Text] [Related]
17. Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigen. Morand-Joubert L; Bludau H; Lerable J; Petit JC; Lefrère JJ J Med Virol; 1995 Sep; 47(1):87-91. PubMed ID: 8551265 [TBL] [Abstract][Full Text] [Related]
18. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection. Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041 [TBL] [Abstract][Full Text] [Related]
19. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity. Chung AW; Mabuka JM; Ndlovu B; Licht A; Robinson H; Ramlakhan Y; Ghebremichael M; Reddy T; Goulder PJR; Walker BD; Ndung'u T; Alter G AIDS; 2018 Jun; 32(10):1207-1217. PubMed ID: 29620716 [TBL] [Abstract][Full Text] [Related]
20. Characterization of human immunodeficiency virus type 1 CRF01_AE env genes derived from recently infected Thai individuals. Chaitaveep N; Utachee P; Nakamura S; Chuenchitra T; Ekpo P; Takeda N; Pattanapanyasat K; Kameoka M Microbes Infect; 2014 Feb; 16(2):142-52. PubMed ID: 24513704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]